Evolent Health, Inc. ( NYSE: EVH) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - ...

EVH earnings call for the period ending December 31, 2024.

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...

Holdings announced the publication of results from the first-in-human interventional study to treat children with ...

"It's nerve-wracking," one Central Islip resident said Tuesday after flying into Long Island MacArthur Airport following a ...

Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...

Mental health support is a crucial aspect that goes beyond a brand’s ethical responsibility to care for its employees. It’s ...

People-pleasing, or putting other's needs before your own, may seem like a positive trait. But people pleasers don't recognize their emotional needs and, deep down, don't think they are important ...

Huckberry’s winter sale is one of the better all-around sales you can find—in regards to both value and utility—and even ...

At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2024 financial results conference call. There will be a question-and-answer session to follow ...

Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunitiesDr. Sabine ...

Accurate monitoring of particle size and growth is essential to ensure scalability in the development of transfection vectors ...